---
title: "Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285945546.md"
description: "A global beauty company, Evolus, Inc. (NASDAQ: EOLS), based in Newport Beach, California, revealed its plan to launch Estyme® in Europe on May 16th. Estyme® comprises four injectable hyaluronic acid (HA) gels, expanding the company's presence in the international dermal filler market. Designed to offer a broad spectrum of aesthetic solutions, this collection signifies Evolus's venture into diversifying its product portfolio."
datetime: "2026-05-11T12:34:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285945546.md)
  - [en](https://longbridge.com/en/news/285945546.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285945546.md)
---

# Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

A global beauty company, Evolus, Inc. (NASDAQ: EOLS), based in Newport Beach, California, revealed its plan to launch Estyme® in Europe on May 16th. Estyme® comprises four injectable hyaluronic acid (HA) gels, expanding the company's presence in the international dermal filler market. Designed to offer a broad spectrum of aesthetic solutions, this collection signifies Evolus's venture into diversifying its product portfolio.

### Related Stocks

- [EOLS.US](https://longbridge.com/en/quote/EOLS.US.md)

## Related News & Research

- [Evolus (NASDAQ:EOLS) Insider Rui Avelar Sells 3,119 Shares](https://longbridge.com/en/news/280002542.md)
- [Evolus Maintains Buy Rating as Scalable Growth Story Solidifies; $13 Price Target Reaffirmed](https://longbridge.com/en/news/285188212.md)
- [Evolus, Inc. (NASDAQ:EOLS) Given Consensus Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/270033683.md)
- [Rui Avelar Sells 2,261 Shares of Evolus (NASDAQ:EOLS) Stock](https://longbridge.com/en/news/271043118.md)
- [Evolus (EOLS) Gets a Buy from Stifel Nicolaus](https://longbridge.com/en/news/272410370.md)